BioGend Therapeutics (6733) Stock Overview

BioGend Therapeutics Co., Ltd. develops regenerative bio-orthopaedic products. It is developing BiG-001 and BiG-006, an osteoinductive bone graft substitute; and BiG-009, an autologous cartilage repair system. The company was founded in 2016 and is based in Taipei, Taiwan.

6733 Stock Information

Symbol

6733

Address

No.3-2, Park StreetTaipei, 115Taiwan

Founded

Trading hours

Website

https://www.biogend.com

Country

🇹🇼 Taiwan

Phone Number

886 2 2655 8366

BioGend Therapeutics (6733) Price Chart

BioGend Therapeutics Overview: Key Details and Summary

Stock data	2024	Change
Price	$1.05	N/A
Market Cap	$128.92M	N/A
Shares Outstanding	123.08M	N/A
Employees	0	N/A